See the DrugPatentWatch profile for Inavolisib
What patent publications exist for inavolisib, and what do they cover?
I can’t answer this accurately from the information provided, because “inavolisib patent publication” could refer to many different patent documents (applications, granted patents, families, and continuation filings) in different jurisdictions. To give you the right publication numbers and what each one covers, I need at least one anchor detail.
Common anchors people use when searching:
- The specific patent number or publication number (e.g., US application/publication, WO publication)
- The assignee/company name (e.g., the company that filed the patents)
- The inventors
- The target (for example, PI3K/AKT/mTOR pathway-related claims) and the intended indication
If you paste a candidate publication number or a link, I can summarize what that particular document claims and how it maps to inavolisib.
How can I find the correct inavolisib patent publication numbers (WO/US/EP)?
A practical way is to search by assignee and compound name together:
- Search for “inavolisib” and also try the synonym/chemical name variations used in filings.
- Add the assignee (the company that markets/owns inavolisib filings).
- Filter by document type: WO (PCT), US application, EP publication, granted patents if you want issued rights.
If you tell me which database you’re using (Google Patents, Lens.org, Espacenet) and the assignee or a suspected WO number, I can suggest the exact search query strings to use.
Are you asking for the first publication date, or the latest/active filings?
People often mean one of these:
- First public publication of inavolisib-related IP (earliest WO/US publication in the family)
- Latest continuation/region filings
- Specific family member in the US/EP/WO that is currently enforceable
Share what you mean by “publication” (first vs latest vs a specific jurisdiction), and I’ll tailor the answer.
When does patent protection for inavolisib expire?
Expiry depends on which patent family member and jurisdiction you mean (application filing date, priority date, and any patent-term adjustments/exclusivities). Without the exact publication/grant number(s), I can’t compute or cite an expiry.
If you provide the WO/US publication number(s) you’re looking at, I can explain how to estimate the likely expiry window and what to check (priority date, claim scope, and whether it was granted).
What to send so I can produce the exact patent publication answer you want
Reply with one of the following:
1) A patent publication number (WO…, US…, EP…)
2) The assignee/company name you’re targeting
3) A link to the publication page you found
4) The query results you see (a few candidate titles/publication numbers)
Once you provide that, I can list the relevant inavolisib patent publication(s) and summarize what each one protects (claimed compounds, methods of treatment, formulations, dosing, and key claim elements), with citations to the exact documents.